Coverage
-
September 01, 2016
A Texas federal judge on Thursday gave preliminary approval of a settlement that would pay shareholders of Pain Therapeutics Inc. up to $8.5 million and release claims the company hid from the market manufacturing issues with its pain treatment Remoxy.
4 other articles on this case.
View all »